Search

1 to 10 of 324
Sort by

Event
11th Breast-Gynecological & Immuno-Oncology International Cancer Conference (BGIICC)

The 11th Breast, Gynecological and Immuno-oncology International Cancer Conference (BGIICC) is the only conference specialized in breast gynecological cancers in Africa and the Middle-East. The 2019 Scientific Program is designed to give a good platform for the exchange of experience on cancers...

 01-17-2019 00:00 - 01-18-2019 23:55 EET
 Cairo Governorate


Library Entry
A severe case of neuro-Sjögren’s syndrome induced by pembrolizumab

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case study of a melanoma patient treated for 8 months with pembrolizumab who developed a subacute ataxic sensory neuronopathy (SNN), including a right trigeminal neuropathy. Authors: Jaqueline Ghosn , Alex Vicino , Olivier...


Library Entry
Clinical Trial Finder: LUNGevity

The LUNGevity clinical trial finder helps people connect with lung cancer clinical trials. Our screening process helps them find nearby clinical trials trials, as well as provides information and links to centers performing these studies. Click here to access the LUNGevity clinical trial...


Library Entry
The 3 C’s of Lung Cancer (Change, Collaboration, and Creation): Highlights of World Lung 2018

This expert blog, written by Upal Basu Roy, MPH, PhD, Director of Translational Research Program/Director of Patient FoRCe at LUNGevity, provides an overview of the latest developments in the treatment of lung cancer presented at the 2018 World Conference for Lung Cancer held in Toronto this...


Library Entry
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report about adverse skeletal effects of immunotherapy, a phenomenon not previously described. Authors: Kendall F. Moseley , Jarushka Naidoo , Clifton O. Bingham , Michael A. Carducci , Patrick M. Forde , ...


Library Entry
Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article about a retrospective study to compare the efficacy of infliximab (IFX) plus corticosteroids (CS) with that of CS alone for the management of Immune-related enterocolitis (irEC). Authors: Daniel H Johnson , ...


Library Entry
Immunotherapy for the Treatment of Genitourinary Cancers: Patient Resource Guide

Published in partnership with the Society for Immunotherapy of Cancer (SITC), the Immunotherapy for the Treatment of Genitourinary Cancers: Patient Resource Guide provides current, medically accurate information intended specifically for patients and their caregivers. Immunotherapy for the...

ImmunotherapyforGenitourinaryCancers.pdf


Library Entry
Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a research article that aims to summarize nivolumab-related serious adverse events (SAEs) and fatal adverse events (FAEs) and to estimate the incidence and risk of SAEs/FAEs by conducting a meta-analysis among adult patients with...


Library Entry
Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a review that provides an overview of the current state of adoptive cell transfer (ACT) with TIL in melanoma, focusing on clinical responses, production and treatment protocols, associated toxicity, as well as the future potential...


Library Entry
Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy

Published in the Journal for ImmunoTherapy of Cancer (JITC), is a case report on the first durable systemic treatment of malignant epithelioid angiomyolipoima with the use of PD-1 antibody nivolumab. Authors: Michael Lattanzi , Fang-Ming Deng , Luis A. Chiriboga , Alisa N. Femia , Shane...